Yezhong Wang
No. 250, Changgang East Road
Guangzhou, 510260, China
Guangzhou, 510260, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Biomimetic immortalized mesenchymal stem cell-based nanoparticles suppress orthotopic postsurgical glioma via CD73 targeting and chemotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 06, 2025
Corrigendum to "Microglia-mediated pericytes migration and fibroblast transition via S1P/S1P3/YAP signaling pathway after spinal cord injury" [Vol. 379 of Experimental Neurology (September 2024)].
Journal: Experimental neurology
Published: January 22, 2025
Regulation of 5-fluorouracil-induced intestinal damage by the interleukin-23/interleukin-22 axis in chemotherapy.
Journal: International immunopharmacology
Published: October 28, 2024
Critical role of Oas1g and STAT1 pathways in neuroinflammation: insights for Alzheimer's disease therapeutics.
Journal: Journal of translational medicine
Published: May 24, 2024
PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration.
Journal: Cell death & disease
Published: April 16, 2024
Microglia-mediated pericytes migration and fibroblast transition via S1P/S1P3/YAP signaling pathway after spinal cord injury.
Journal: Experimental neurology
Published: March 15, 2024
PRMT1 in human neoplasm: cancer biology and potential therapeutic target.
Journal: Cell communication and signaling : CCS
Published: December 06, 2023
Increased level of exosomal miR-20b-5p derived from hypothermia-treated microglia promotes neurite outgrowth and synapse recovery after traumatic brain injury.
Journal: Neurobiology of disease
Published: November 18, 2022
Glucose-albumin ratio as new biomarker for predicting mortality after intracerebral hemorrhage.
Journal: Neurosurgical review
Published: October 31, 2022
PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B.
Journal: Oncogene
Published: October 14, 2022
Last Updated: 09/26/2026